Human Psychopharmacology-Clinical and Experimental

Papers
(The median citation count of Human Psychopharmacology-Clinical and Experimental is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Issue Information27
Issue Information24
Elevated serum levels of TNF‐α, IL‐6, and IL‐18 in chronic methamphetamine users19
Issue Information17
Could improved recognition and treatment of anxiety disorders lead to a reduction in suicide?17
16
Issue Information14
‘Nico’—A lone voyager in Strange Seas13
Trajectories of sentiment in 11,816 psychoactive narratives12
12
J Guy Edwards, FRCPsych, FRCP, FRCGP (Hon), DPM, HonMFPH, Founding Editor of Human Psychopharmacology12
Issue Information12
The type 2 diabetes mellitus susceptibility gene CDKAL1 polymorphism is associated with depressive symptom in first‐episode drug‐naive schizophrenic patients11
The use of antipsychotics in obsessive compulsive disorder10
Comparative evaluation of craving, sleep quality, sexual function and quality of life in opioid use disorder patients in remission with buprenorphine/naloxone maintenance treatment9
The prevalence of constipation in adult psychiatric out‐patients on clozapine treatment at a regional public hospital in Hong Kong8
Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta‐analysis7
7
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression7
Peripheral edema associated with antidepressant use: Systematic review of case reports7
Patient outcome following selective serotonin reuptake inhibitor prescribing in primary care in Wales (UK)7
Ayahuasca may help to improve self‐compassion and self‐criticism capacities6
Analysis of schizophrenia‐associated genetic markers in the HLA region as risk factors for tardive dyskinesia5
Acute Administration of 10 mg Methylphenidate on Cognitive Performance and Visual Scanning in Healthy Adults: Randomised, Double‐Blind, Placebo‐Controlled Study5
Effect of fasedienol (PH94B) pherine nasal spray and steroidal hormones on electrogram responses and autonomic nervous system activity in healthy adult volunteers5
5
Inflammatory markers at baseline correlate with subsequent clinical response to quetiapine in patients with bipolar disorder4
Co‐ingestion of prescription drugs and alcohol in US adults aged 50 years or older4
Efficacy and safety of lemborexant as an alternative drug for patients with insomnia taking gamma‐aminobutyric acid–benzodiazepine receptor agonists or suvorexant4
Corrigendum4
Efficacy of the nootropic supplement Mind Lab Pro on memory in adults: Double blind, placebo‐controlled study4
4
Issue Information4
Experience and views of healthcare professionals towards people who use new psychoactive substances: Evidence from statutory, non‐statutory, and private mental health and addiction healthcare services3
Comparison of naltrexone implant and oral buprenorphine‐naloxone in the treatment of opiate use disorder3
3
Serotonin transporter availability, neurocognitive function and their correlation in abstinent 3,4‐methylenedioxymethamphetamine users3
3
Hypothalamic‐pituitary‐adrenal and autonomic response to psychological stress in abstinent alcohol use disorder individuals with and without depressive symptomatology3
5‐MeO‐DMT has not been found in traditional ayahuasca preparations and the combination of 5‐MeO‐DMT with MAOIs is dangerous3
Initiation of psychotropic medication in hospitalized patients with COVID‐19: Association with clinical and biological characteristics3
Role of serotonin transporter and receptor gene polymorphisms in treatment response to selective serotonin reuptake inhibitors in major depressive disorder2
A diffusion tensor imaging study in schizophrenia patients with clozapine induced obsessive compulsive symptoms2
Issue Information2
Effects of Cannabis‐Delivered THC on mood and negative attentional bias in the context of positive vs. neutral Alternatives—a pilot study2
Lithium in bipolar depression: A review of the evidence2
Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first‐episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms2
Antipsychotic‐Treated Schizophrenia Patients Develop Inflammatory and Oxidative Responses Independently From Obesity: However, Metabolic Disturbances Arise From Schizophrenia‐Related Obesity2
2
2
Aroma of the essential oil of peppermint reduces aggressive driving behaviour in healthy adults2
A Naturalistic Examination of the Acute Effects of High‐Potency Cannabis on Emotion Regulation Among Young Adults: A Pilot Study2
2
The factor structure of extrapyramidal symptoms evaluated using the Drug‐Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP‐4 study2
Facilitated extinction of conditioned fear responses by delta 9‐tetrahyrdrocannabidol in humans: a pilot study1
The first patient to receive olanzapine: A recollection1
1
Prospective analysis of serum prolactin levels, clinical symptomatology and sexual functions in patients with schizophrenia switched to paliperidone palmitate 3‐monthly from paliperidone palmitate 1‐m1
1
The impact of adjunctive aripiprazole on QT interval: A 12‐week open label study in patients on olanzapine, clozapine or risperidone1
Agomelatine as Antidepressant Treatment in Elderly Patients With Previous Hyponatremia Due To SSRI Use: Case Series1
Dexamphetamine increased speech and visual unimodal illusions in healthy participants without affecting temporal binding window1
Factors influencing concentrations of risperidone and 9‐hydroxyrisperidone in psychiatric outpatients taking immediate‐release formulations of risperidone1
Effects of solriamfetol on on‐the‐road driving in participants with narcolepsy: A randomised crossover trial1
Can antidepressant use be associated with emotional blunting in a subset of patients with depression? A scoping review of available literature1
Nick Drake: A Troubled Mind, a Troublesome ‘Cure’1
A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults1
SSRIs in the course of COVID‐19 pneumonia: Evidence of effectiveness of antidepressants on acute inflammation. A retrospective study1
Does sodium oxybate inhibit brain dopamine release in humans? An exploratory neuroimaging study1
Plasma levels of interleukin‐8 and response to paroxetine in patients with major depressive disorder1
Issue Information0
How prevalent and severe is addiction on GABAmimetic drugs in an elderly German general hospital population? Focus on gabapentinoids, benzodiazepines, and z‐hypnotic drugs0
0
Issue Information0
Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof‐of‐concept, randomized, placebo‐controlled trials0
Efficacy and acceptability of adjunctive n‐acetylcysteine for psychotic disorders: Systematic review and meta‐analysis0
Low‐dose ketamine infusion in treatment‐resistant double depression: Revisiting the adjunctive ketamine study of Taiwanese patients with treatment‐resistant depression0
Valproate‐associated hair abnormalities: Pathophysiology and management strategies0
Issue Information0
Issue Information0
Alcohol Consumption During the COVID‐19 Pandemic: A Critical Review0
Efficacy of tiapride in the treatment of psychiatric disorders: A systematic review0
Issue Information0
0
Issue Information0
Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits0
Adiponectin predicts poor response to antidepressant drugs in major depressive disorder0
Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings0
Duloxetine attenuates pain in association with downregulation of platelet serotonin transporter in patients with burning mouth syndrome and atypical odontalgia0
Corrigendum0
The chemical induction of synaesthesia0
Obstacles to treatment retention in opioid use disorder: An international substance use disorder treatment worker survey0
Renal effects of long‐term lithium therapy, revisited0
Nx4 attenuated stress‐induced activity of the anterior cingulate cortex—A post‐hoc analysis of a randomized placebo‐controlled crossover trial0
Response efficacy and heterogeneity of antipsychotic drugs in schizophrenia: Systemic review and meta‐analysis0
The potential role of lysergic acid diethylamide for psychological assisted therapy: A meta‐analysis of randomised controlled trials in healthy volunteers0
Comparison of potential psychiatric drug interactions in six drug interaction database programs: A replication study after 2 years of updates0
Baseline Exposure to Antipsychotic Medication in Young People at Clinical High Risk for Psychosis: A 2‐Year Italian Follow‐Up Study0
Evaluation of memantine's efficacy and safety in the treatment of children with autism spectrum disorder: A systematic review and meta‐analysis0
Effects of COVID‐19 Lockdowns on Alcohol Consumption, Hangovers and Smoking Among Young Adults (n = 140) in Germany: An On‐Line Study0
0
Prescribing patterns in patients with obsessive‐compulsive disorder: Retrospective, single‐center study0
Bi‐directional and multi‐modal effects of dexamphetamine on spatial binding windows in healthy individuals0
Issue Information0
Probable effects of polypharmacy and equivalent doses of psychotropic drugs on prevalence of adverse drug events among psychiatric inpatients in a general hospital in Japan0
Can placebo or nocebo pills improve or impair cognition performance?0
0
Characteristics of antipsychotic drug‐induced hypothermia in psychogeriatric inpatients0
Efficacy and safety of endoxifen in bipolar disorder: A systematic review0
High‐dose Vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression0
0
Professor Brian Leonard: Former Editor‐in‐Chief of Human Psychopharmacology0
Belief in caffeine's ergogenic effect on cognitive function and endurance performance: A sham dose‐response study0
Association of serotonin transporter gene polymorphism with efficacy of the antidepressant drugs sertraline and mirtazapine in newly diagnosed patients with major depressive disorders0
0
Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea0
Dexamphetamine influences funneling illusion based on psychometric score0
Melatonin and melatonin‐agonists for metabolic syndrome components in patients treated with antipsychotics: A systematic review and meta‐analysis0
Psychopharmacoepidemiology of antidepressant medications among homeless and unstably housed service users in the Veterans Affairs healthcare system0
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans0
Issue Information0
Issue Information0
Issue Information0
0
Stress, caffeine and psychosis‐like experiences—A double‐blind, placebo‐controlled experiment0
Issue Information0
Issue Information0
Oral intake of carboxy alkyl ester improves attention: A randomized double‐blind cross‐over placebo‐controlled study0
Restless Legs Syndrome among patients receiving antipsychotic and antidepressant drugs0
Opioid analgesics prescribing trends 2010–2019 in Slovenia: National database study0
Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment‐free Russian patients with moderate or severe depression: An explorative psychopharmacological st0
The impact of alcohol consumption on commercial eye blink drowsiness detection technology0
0
0
Efficacy of naltrexone in borderline personality disorder, a retrospective analysis in inpatients0
Treatment of depression: Are psychotropic drugs appropriately dosed in women and in the elderly? Dosages of psychotropic drugs by sex and age in routine clinical practice0
Issue Information0
N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine0
Issue Information0
0
Issue Information0
0
Issue Information0
0
Effects of atypical antipsychotics on serum asprosin level and other metabolic parameters in patients with schizophrenia0
Exploring the understanding, source of availability and level of access of cognitive enhancers among university students in the United Arab Emirates: A qualitative study0
Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine—A literature review0
Potential processes of change in MDMA‐Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self‐transcendence, and therapeutic relationships0
Reply to: 5‐MeO‐DMT has not been found in traditional ayahuasca preparations and the combination of 5‐MeO‐DMT with MAOIs is dangerous0
Issue Information0
Effects of the active botanical blend “WKUP GT” on attention and cognitive functions after lunch in healthy volunteers0
Efficacy and safety of hydroxyzine for sleep in adults: Systematic review0
The antimuscarinic agent biperiden selectively impairs recognition of abstract figures without affecting the processing of non‐words0
A narrative review of the neuropharmacology of synthetic cathinones—Popular alternatives to classical drugs of abuse0
Estradiol treatment in young postmenopausal women with self‐reported cognitive complaints: Effects on cholinergic‐mediated cognitive performance0
Safety and efficacy of Withania somnifera for anxiety and insomnia: Systematic review and meta‐analysis0
0.13476395606995